On June 25, 2025, during the 23rd World Pharmaceutical Ingredients China Exhibition (CPhI China), Hunan Aisun Technology Group Co., Ltd. was honored with the title of one of the “Top 10 Sustainable International Supply Chain Enterprises in China’s Pharmaceutical Industry” after a rigorous evaluation by the China Chamber of Commerce for Import and Export of Medicines and Health Products.

The award ceremony was personally hosted by Mr. Wang Maochun, Vice President of the Chamber, and was grandly held at the Aisun Group exhibition booth.

As an authoritative organization in China’s pharmaceutical import and export sector, the China Chamber of Commerce for Import and Export of Medicines and Health Products is one of the six major national import-export chambers, dedicated to promoting the internationalization of China’s healthcare industry. Meanwhile, CPhI China is the largest and most internationalized pharmaceutical ingredients exhibition in Asia, gathering thousands of pharmaceutical enterprises from around the world.

This recognition is a strong affirmation of Aisun Group’s long-term commitment to social and environmental responsibility, quality management, compliance system development, and its capability to fulfill responsibilities to global clients. It also fully acknowledges the Group’s efforts in strengthening the stability and resilience of international supply chains. This honor belongs not only to Aisun, but also to all partners who have supported and worked alongside us.

Since its establishment over a decade ago, Aisun Group has consistently adhered to the development philosophy of “customer-centricity and value creation.” The Group has been awarded multiple honors, including “Most Growth-Potential Enterprise” among the Top 100 in Pharmaceutical Internationalization and “Quality Supplier.” Taking this achievement as a new starting point, Aisun Group will continue to enhance its service capabilities, support the global healthcare industry, promote a win-win ecosystem, and strive to build a world-leading health industry supply chain service group.

Looking ahead, Aisun Group will continue to uphold the principles of sustainable development, contributing to a more efficient, green, and compliant new stage of globalization for China’s pharmaceutical industry.